[Molecular basis of Hodgkin lymphoma and anaplastic large cell lymphoma and molecular targeting therapy by an NF-kappaB inhibitor].
Horie
Ryoichi
R
D018390:Gene Targeting; D015316:Genetic Therapy / Q000379:methods; D006689:Hodgkin Disease / Q000235:genetics* / Q000628:therapy*; D006801:Humans; D017730:Ki-1 Antigen; D016403:Lymphoma, Large B-Cell, Diffuse / Q000235:genetics* / Q000628:therapy*; D016328:NF-kappa B / Q000037:antagonists & inhibitors*; D011505:Protein-Tyrosine Kinases
D017730:Ki-1 Antigen; D016328:NF-kappa B; C107023:p80(NPM-ALK) protein; D011505:Protein-Tyrosine Kinases